Wells Fargo
PPH icon

Wells Fargo’s VanEck Pharmaceutical ETF PPH Stock Holding History

Wells Fargo’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.8K Sell
431
-499,674
-100% -$53.2M ﹤0.01% 5491
2025
Q4 		$51.6M Sell
500,105
-375
-0.1% -$36.5K 0.01% 916
2025
Q3 		$45.2M Buy
500,480
+97,493
+24% +$8.54M 0.01% 975
2025
Q2 		$35.4M Buy
+402,987
New +$34.9M 0.01% 1041
2025
Q1 		– Sell
-252
Closed -$22.7K – 6538
2024
Q4 		$21.8K Buy
252
+131
+108% +$11.8K ﹤0.01% 5744
2024
Q3 		$11.5K Sell
121
-764
-86% -$72.6K ﹤0.01% 5766
2024
Q2 		$81K Hold
885
– – ﹤0.01% 5068
2024
Q1 		$80.3K Buy
885
+884
+88,400% +$77.4K ﹤0.01% 5025
2023
Q4 		$60 Sell
1
-625
-100% -$49K ﹤0.01% 6894
2023
Q3 		$50K Sell
626
-5,214
-89% -$420K ﹤0.01% 5174
2023
Q2 		$460K Buy
5,840
+1,162
+25% +$91K ﹤0.01% 4012
2023
Q1 		$363K Sell
4,678
-301
-6% -$23.2K ﹤0.01% 4056
2022
Q4 		$387K Buy
4,979
+300
+6% +$22.1K ﹤0.01% 3788
2022
Q3 		$315K Hold
4,679
– – ﹤0.01% 3975
2022
Q2 		$360K Buy
4,679
+400
+9% +$31.2K ﹤0.01% 3945
2022
Q1 		$341K Sell
4,279
-400
-9% -$30.6K ﹤0.01% 4673
2021
Q4 		$360K Buy
4,679
+1
+0% +$74 ﹤0.01% 4926
2021
Q3 		$341K Hold
4,678
– – ﹤0.01% 4872
2021
Q2 		$342K Sell
4,678
-1
-0% -$71 ﹤0.01% 4803
2021
Q1 		$323K Sell
4,679
-49
-1% -$3.38K ﹤0.01% 4930
2020
Q4 		$314K Sell
4,728
-21
-0.4% -$1.35K ﹤0.01% 4855
2020
Q3 		$295K Sell
4,749
-62
-1% -$3.92K ﹤0.01% 4727
2020
Q2 		$299K Sell
4,811
-1,000
-17% -$60.5K ﹤0.01% 4670
2020
Q1 		$316K Sell
5,811
-2,040
-26% -$126K ﹤0.01% 4381
2019
Q4 		$503K Sell
7,851
-149,999
-95% -$9.04M ﹤0.01% 4362
2019
Q3 		$9M Buy
157,850
+149,718
+1,841% +$8.58M ﹤0.01% 2023
2019
Q2 		$477K Sell
8,132
-13
-0.2% -$753 ﹤0.01% 4413
2019
Q1 		$495K Buy
8,145
+663
+9% +$39.2K ﹤0.01% 4339
2018
Q4 		$410K Sell
7,482
-400
-5% -$24.2K ﹤0.01% 4462
2018
Q3 		$507K Sell
7,882
-80
-1% -$4.99K ﹤0.01% 4426
2018
Q2 		$470K Hold
7,962
– – ﹤0.01% 4500
2018
Q1 		$452K Buy
7,962
+80
+1% +$4.78K ﹤0.01% 4468
2017
Q4 		$467K Buy
7,882
+282
+4% +$16.2K ﹤0.01% 4451
2017
Q3 		$439K Sell
7,600
-1,000
-12% -$56.8K ﹤0.01% 4420
2017
Q2 		$508K Sell
8,600
-200
-2% -$11.3K ﹤0.01% 4213
2017
Q1 		$485K Buy
8,800
+1,816
+26% +$98.5K ﹤0.01% 4266
2016
Q4 		$367K Buy
6,984
+184
+3% +$9.83K ﹤0.01% 4407
2016
Q3 		$390K Buy
6,800
+49
+0.7% +$2.94K ﹤0.01% 4090
2016
Q2 		$396K Buy
6,751
+151
+2% +$8.8K ﹤0.01% 4041
2016
Q1 		$379K Buy
6,600
+1,600
+32% +$94.6K ﹤0.01% 4041
2015
Q4 		$327K Hold
5,000
– – ﹤0.01% 4162
2015
Q3 		$315K Sell
5,000
-400
-7% -$28.1K ﹤0.01% 4217
2015
Q2 		$382K Buy
5,400
+400
+8% +$28.8K ﹤0.01% 4252
2015
Q1 		$351K Hold
5,000
– – ﹤0.01% 4145
2014
Q4 		$321K Buy
5,000
+4,000
+400% +$255K ﹤0.01% 4181
2014
Q3 		$64K Hold
1,000
– – ﹤0.01% 4841
2014
Q2 		$62K Hold
1,000
– – ﹤0.01% 4883
2014
Q1 		$58K Sell
1,000
-3,400
-77% -$192K ﹤0.01% 4877
2013
Q4 		$234K Sell
4,400
-200
-4% -$10.1K ﹤0.01% 4173
2013
Q3 		$220K Sell
4,600
-200
-4% -$9.48K ﹤0.01% 4166
2013
Q2 		$218K Buy
+4,800
New +$222K ﹤0.01% 4091

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BCIM
British Columbia Investment Management Victoria, British Columbia, Canada $17B AUM 31.69% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $11.4B AUM 21.6% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.45B AUM 35.31% 1-Year Est. Return

Wells Fargo's PPH Position: Q1 2026 in Review

Wells Fargo reduced its VanEck Pharmaceutical ETF (PPH) stake by 100% in Q1 2026, selling an estimated $53.2M and leaving 431 shares worth $44.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5491.

Wells Fargo first reported a position in PPH in Q2 2013 and has held it in 51 quarters since. The position peaked at $51.6M in Q4 2025. 147 funds tracked by Wall St. Rank hold PPH as of Q1 2026.

  • Wells Fargo held 431 shares of VanEck Pharmaceutical ETF worth $44.8K as of Q1 2026.
  • Wells Fargo sold 499,674 VanEck Pharmaceutical ETF shares in Q1 2026, an estimated $53.2M.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5491 holding.
  • Wells Fargo first reported a position in VanEck Pharmaceutical ETF in Q2 2013 and has held it in 51 quarters since.
  • Wells Fargo's VanEck Pharmaceutical ETF position peaked at $51.6M in Q4 2025.
  • 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.